Share

Shanghai GenTech Co., Ltd. Stocks

CN¥ 31.86Last Updated 15.04.2026

Issuer Rating

4/7
Performance

Average

Risk

Limited

Recommendation

Hold

Market Cap

CN¥ 1.27B

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CN¥ 31.86
Key Takeaways

Risk factor

Good trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Good margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Shanghai GenTech Co., Ltd. provides process critical system solutions to customers in hi-tech and advanced manufacturing industries in China. The company offers specialty gases and chemicals, such as arsine, phosphine, silane, ammonia, TMA, various gas mixtures, and other electronic materials; and process critical systems, including process delivery systems, vacuum and exhaust (waste) gas treatment systems, life safety and process monitoring systems, and clean process material systems. It also provides material recovery and recycling; new energy-storage medium; bioseparation and purification; and maintenance, repair, and operation service systems. The company offers its products to IC, flat panel display, solar photovoltaics, LED lighting, optical fiber manufacturing, and bio-pharmaceutical businesses. Shanghai GenTech Co., Ltd. was founded in 2009 and is Shanghai, China.

Company Valuation

Fairly valued
4/7

From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. Specifically, the stock is fairly valued on P/E, neutral on EV/EBIT

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks